Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance.
- DOI
- 10.1097/cad.0000000000000647
- Published
- 2018 Sep
- Container
- Anti-cancer drugs
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/cad.0000000000000647,
title = {Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance.},
author = {Wang Y and Liu Q and Chen H and You J and Peng B and Cao F and Zhang X and Chen Q and Uzan G and Xu L and Zhang D},
year = {2018},
journal = {Anti-cancer drugs},
doi = {10.1097/cad.0000000000000647},
url = {https://doi.org/10.1097/cad.0000000000000647}
}RIS
TY - JOUR TI - Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. AU - Wang Y AU - Liu Q AU - Chen H AU - You J AU - Peng B AU - Cao F AU - Zhang X AU - Chen Q AU - Uzan G AU - Xu L AU - Zhang D PY - 2018 JO - Anti-cancer drugs DO - 10.1097/cad.0000000000000647 UR - https://doi.org/10.1097/cad.0000000000000647 ER -
APA
Y, W., Q, L., H, C., J, Y., B, P., F, C., X, Z., Q, C., G, U., L, X., & D, Z. (2018). Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance.. Anti-cancer drugs. https://doi.org/10.1097/cad.0000000000000647
Source records
- pubmed · retrieved 2026-09-26T21:27:14.449Z
- europe-pmc · retrieved 2026-09-26T21:27:14.459Z
- hal · retrieved 2026-09-26T21:27:14.485Z